Alexandra Gerogianni

Lund University — Sweden

Immunology and Microbiology · Life Sciences

7h-index425citations13works8.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complement system in diseases(10), Platelet Disorders and Treatments(4), Blood Coagulation and Thrombosis Mechanisms(3), Hemoglobinopathies and Related Disorders(2), Immune Cell Function and Interaction(2)

Publications13 total

Bradykinin B1 receptor signaling triggers complement activation on endothelial cells
Frontiers in Immunology·2025· 1 citedOpen Access
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum
Kidney International·2024· 16 citedOpen Access
Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE
Frontiers in Immunology·2023· 7 citedOpen Access
138 Escherichia coli-induced platelet aggregation in human whole blood is partly dependent on complement C3b
Immunobiology·2023
In vitro evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell model
Frontiers in Immunology·2023· 15 citedOpen Access
The role of the thromboinflammatory response under hemolytic conditions: pathophysiological mechanisms and therapeutic inhibition
2023Open Access
Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood
Frontiers in Immunology·2022· 11 citedOpen Access
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
Frontiers in Immunology·2022· 23 citedOpen Access
Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood
The Journal of Immunology·2019· 41 citedOpen Access
Complement (C5)-inhibition attenuates heme-induced inflammation in human whole blood
Molecular Immunology·2018
Tailoring the specificity of the type C feruloyl esterase FoFaeC from Fusarium oxysporum towards methyl sinapate by rational redesign based on small molecule docking simulations
PLoS ONE·2018· 16 citedOpen Access
ERRATUM
Journal of Clinical Oncology·2006· 1 citedOpen Access
Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
Journal of Clinical Oncology·2006· 294 citedOpen Access

Frequent Co-authors

Per H. Nilsson(7), Tom Eirik Mollnes(6), Corinna Lau(3), Diana Karpman(3), Andrea Bezjak(2), Dongsheng Tu(2), Lesley Seymour(2), Gary M. Clark(2), Aleksandra Trajković(2), Mauro Zukin(2), Joseph Ayoub(2), S. Lago(2), Arnold Cyjon(2), Jonathan Noble(2), Francis Laberge(2), David Fenton(2), Anub Mathew Thomas(2), Martin B. McAdam(2), Andreas Barratt‐Due(2), Camilla Mohlin(2)